Net Equity and Corporate Financing in Europe: A Comparative Analysis of German, Austrian, Spanish, French and Italian Manufacturing Companies With Share Capital During The Period 1991-1993

1998 ◽  
Author(s):  
Michel Delbreil ◽  
José Ramon Cano ◽  
Hans Friderichs ◽  
Benoit Gress ◽  
Bernard Paranque ◽  
...  
Keyword(s):  
Comparative Analysis ◽  
Manufacturing Companies ◽  
Corporate Financing ◽  
Share Capital ◽  
Net Equity

Comparative analysis of business models of top pharmaceutical manufacturing companies: fifi nancial analysis

2020 ◽  
pp. 43-52
Author(s):  
L.E. Yasinskaya ◽  
Keyword(s):  
Comparative Analysis ◽  
Business Models ◽  
Financial Analysis ◽  
Active Pharmaceutical Ingredient ◽  
Pharmaceutical Companies ◽  
Manufacturing Companies ◽  
Revenue Growth ◽  
Commercial Activities ◽  
Pharmaceutical Manufacturers ◽  
Research Procedure

Introduction. Earlier, the comparative analysis of the commercial and investment activities of the companies that play the key roles in the investment processes in the Russian pharmaceutical industry and operate within the four main business models (biotechnological, generic, specialized pharmaceutical companies, active pharmaceutical ingredient (API) manufacturers) has been conducted. No full assessment of the companies’ activitiesis conceivable without a financial analysis of their activities to identify the risks of investment activities. Objective of the study. A detailed comparative analysis of the financial standing of domestic pharmaceutical manufacturers operating within the selected business models for further identification of potential financial risks for investors. Research procedure and article structure. Analysis of RAS statements (forms 1 and 2) of 72 over 500 million revenue companies grouped together as selected business models for the period from 2015 to 2019. Results. The researchers provided a detailed description of the commercial activities of domestic pharmaceutical companies within the business models under consideration. The companies within various business models showed positive revenue growth rates over the past five years. All business models demonstrate consistently high business profitability and a significant share of own capital in the asset profile. Conclusion. The results of the study show the stable financial standing of the pharmaceutical companies within various business models. The biotechnology sector companies that are the most attractive for investments have the highest quality financial standing. The specialized and generic companies show similar consistently strong performance. API manufacturers that the companies with relatively small revenues are actively developing and are attractive to restrained budget investors.

scholarly journals Market size and foreign trade as determinants of national competitiveness sustainability

2020 ◽  
Vol 4 (2) ◽  
pp. 25-33
Author(s):  
Milica Jovanović ◽  
Aleksandar Đorđević
Keyword(s):  
Comparative Analysis ◽  
Foreign Trade ◽  
Foreign Market ◽  
The Other ◽  
Market Size ◽  
Manufacturing Companies ◽  
Large Market ◽  
National Competitiveness ◽  
National Market ◽  
Small Market

Market size in many ways determines the national competitiveness of an economy. If there is a large national market, it is a source of demand for manufacturing companies. There are cases where the national economy has a large market and a weak industry, e.g. Russia, while on the other hand, Switzerland, which has a small market size, compensates that with productivity and exports to other markets. Market size and foreign trade complement each other in influencing the sustainability of national competitiveness. If there is a large market and insufficient industry to meet the demand in that market, it is necessary to import the products and satisfy the needs of the domestic market. However, the small national market and the production of a large quantity of products that it cannot absorb requires export to other markets. The paper presents a comparative analysis of the competitiveness of Serbia and countries in the region, and their indices of market sizes, which include, but are not limited to, foreign market percentages and exports. Certainly, both determinants significantly affect national competitiveness and its sustainability.

scholarly journals Dental and medical advertising: comparative analysis of the rules of professional conduct

2018 ◽  
Vol 66 (2) ◽  
pp. 166-171
Author(s):  
Luciana Vigorito MAGALHÃES ◽  
Tamara Soledad Frontanilla RECALDE ◽  
Marcos Vinícius COLTRI ◽  
Hermes de Freitas BARBOSA ◽  
Marco Aurelio GUIMARÃES ◽  
...  
Keyword(s):  
Health Care ◽  
Comparative Analysis ◽  
Mass Media ◽  
Research Study ◽  
Professional Conduct ◽  
Manufacturing Companies ◽  
Medicine Information ◽  
Professional Activities ◽  
Medical Regulation ◽  
Code Of Professional Conduct

ABSTRACT In health care professional activities, advertising is an issue that raises serious discussions and is the cause of some ethical suits in professional entities, since every advertising should follow the provisions of the Code of Professional Responsibility. Therefore, this research study aimed at analyzing, comparing and discussing articles related to advertising and marketing, considering the current regulations from dental and medical entities. In Dentistry, this subject is ruled by the Code of Professional Conduct, Chapter XVI, ‘From advertising and marketing’. In Medicine, information is found in two regulations and in several chapters of the Code of Medical Ethics and in Resolution No. 1.974/2011 of the Federal Council of Medicine, which establishes the guiding criteria for medical advertising. The three regulations present articles that refers to participation in mass media, required information in advertisements, use of sensationalism and self-promotion, and publishing of unproven specialties and titles, highlighting the importance of these topics. The medical regulation also includes participation in publishing ads of manufacturing companies and an exclusive committee to deal with advertising and marketing issues, topics that are not considered in the dental regulation.

scholarly journals Financial Participation of Public Partners in Public-Private Partnership

2020 ◽  
Vol 12 (6) ◽  
pp. 87-99
Author(s):  
M.I. Kudelich ◽  
Keyword(s):  
Comparative Analysis ◽  
Public Private Partnership ◽  
The State ◽  
Debt Financing ◽  
Private Partnership ◽  
Share Capital ◽  
High Security ◽  
Legislative Regulation ◽  
Financial Participation

This article attempts to identify and analyze the problems of forms of financial participation of public partners in PPP agreements, which may be solved by legislation improvement. The article presents a comparative analysis of Russian and international practice and legislation in the field of types and procedures for choosing forms of state financial participation in PPP projects. Conclusions are made about the absence of formal criteria for choosing the form of financial participation of a public partner in the PPP agreement and the rules for determining their volume, about the uncertainty and shortcomings of legislative regulation of “financial provision” in relation to a public partner, about the refusal from using the provision of debt financing and budget investments in share capital of project companies, on the establishment of high security budgetary requirements for regressive rights of the state in relation to the principal, which make the use of state (municipal) guarantees unclaimed in Russian practice of PPP projects.

scholarly journals Mezzanine as an alternative form of corporate financing

2015 ◽  
Vol 6 (1) ◽  
pp. 99
Author(s):  
Agnieszka Czajkowska
Keyword(s):  
Comparative Analysis ◽  
Mergers And Acquisitions ◽  
Alternative Form ◽  
Transactions Costs ◽  
Alternative Source ◽  
Corporate Financing ◽  
Investment Projects ◽  
Advantages And Disadvantages ◽  
Alternative Funding ◽  
The Usa

The main goal of the article is the assessment of mezzanine financing as an innovative form in Poland, which might play a significant role in the dynamically developing companies which can’t obtain sufficient capital from traditional sources in the form of bank credits. Mezzanine may be applied to: financing investment projects, increasing the value of the company, the expansion of businesses through mergers and acquisitions, redemption of shares or the financing of leveraged buyouts. The main methodology used in this article is explanatory research and comparative analysis. The hypothesis assumes that mezzanine financing may become an important alternative source of funding for medium and large sized enterprises in Poland. This article presents the idea of mezzanine financing, its mechanism, structures and comparison to alternative funding, examples of such transactions costs. An important part is indication of types of mezzanine capital and applications in the USA, the UE including Poland as well as comparative analysis of mezzanine advantages and disadvantages.

scholarly journals Prediction of Financial Distress in Manufacturing Company: A Comparative Analysis of Springate Model and Fulmer Model

2019 ◽  
Vol 7 (2) ◽  
pp. 63-72
Author(s):  
Raid Ayasy Shalih ◽  
Fariyana Kusumawati
Keyword(s):  
Comparative Analysis ◽  
Financial Distress ◽  
Stock Exchange ◽  
Secondary Data ◽  
Financial Statements ◽  
Manufacturing Companies ◽  
Relevant Model ◽  
Analysis Technique ◽  
The One ◽  
One Way Anova

This research aims to analyze the differences in financial distress predictions between the Springate model and the Fulmer model. The method used in this research is quantitative. The type of data used in this research is secondary data in the form BEI of company financial statements for 2014-2016. The data analysis technique uses the One Way ANOVA test. The results showed that there are significant differences between the Springate model and the Fulmer model in predicting financial distress in manufacturing companies listed on the Indonesia stock exchange during 2014-2016. The most relevant model in predicting financial distress in this study is the Springate model.

Sign in / Sign up

Export Citation Format

Share Document